TrialJournal of the American Heart Association2024

Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial.

Masaharu Akao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.